Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Worldwide Offices
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Visiongain publishes Antibacterial Drugs Market 2020-2030 report

      This image opens in the lightbox

      News provided by

      Visiongain

      31 Aug, 2020, 08:00 GMT

      Share this article

      Share this article


      Forecasts by Type (Cephalosporins (Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam, Others), Penicillins (Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic Amoxicllin-clavulanic Acid, Amoxil, Others), Fluoroquinolones (Avelox, Cravit, Vigamox, Ciprodex, Cipro/Cirpobay, Geninax, Baxdela, Others), Macrolides (Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin, Others), by Carbapenems (Invanz, Merrem/Meropen, Primaxin, Doribax, Others), Others (Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin)), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, E-Commerce), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Analysis of Leading Drug Discovery Outsourcing Companies. PLUS, COVID-19 Recovery Scenarios

      LONDON, Aug. 31, 2020 /PRNewswire/ -- Antibacterial Drugs– our new study reveals trends, R&D progress, and predicted revenues

      Where is the Antibacterial Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

      Discover how to stay ahead

      Our 391 page report provides 231 Tables and 285 Figures. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibacterial Drugs Market. See how to exploit the opportunities.

      Forecasts to 2030 and other analyses reveal the commercial prospects

      • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.

      • You find original analyses, with business outlooks and developments.

      • Discover qualitative analyses (including market drivers, restraints/challenges, opportunities, PEST, SWOT, and Porter's Fiver Forces Analysis), company profiles (financials 2015 to 2020, products, recent developments.

      This Visiongain report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

      To access the data contained in this document please email contactus@visiongain.com

      To request sample pages from this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/antibacterial-drugs-market-2020/#download_sampe_div

      Discover sales predictions for the world market and submarkets

      Global Antibacterial Drugs Market Segmentation

      By Type

      • Cephalosporins

      • Penicillins

      • Fluoroquinolones

      • Macrolides

      • Carbapenems

      • Others

      By Cephalosporins

      • Rocephin

      • Sulperazon

      • Ceftin/Zinnat

      • Meiact

      • Flomox

      • Teflaro

      • Zeftera

      • Ceftolozane-tazobactam

      • Ceftazidime-Avibactam

      By Penicillins

      • Generic Amoxicillin

      • Augmentin

      • Zosyn/Tazocin

      • Unasyn

      • Generic amoxicllin-clavulanic acid

      • Amoxil

      • Others

      By Fluoroquinolones

      • Avelox

      • Cravit

      • Vigamox

      • Ciprodex

      • Cipro/Cirpobay

      • Geninax

      • Baxdela

      • Others

      By Macrolides

      • Biaxin/Clarith

      • Zithromax

      • Dalacin

      • Dificid

      • Solithromycin

      • Others

      By Carbapenems

      • Invanz

      • Merrem/Meropen

      • Primaxin

      • Doribax

      • Others

      By Other Sectors

      • Zyvox

      • Cubicin

      • Tygacil

      • TOBI/TIP

      • Solodyn

      • Vibativ

      • Sirturo

      • Tedizolid

      • Oritavancin

      • Dalbavancin

      • Nemonoxacin

      • Surotomycin

      • Others

      By Distribution Channel

      • Hospital Pharmacies

      • Drug Stores & Retail Pharmacies

      In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

      North America

      • U.S.

      • Canada

      Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Russia

      • Rest of Europe

      Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Rest of Asia Pacific

      Latin America

      • Brazil

      • Mexico

      • Argentina

      • Rest of LATAM

      Middle East and Africa

      • GCC

      • South Africa

      • Rest of MEA

      The report also includes profiles and for some of the leading 15 companies in the Antibacterial Drugs Market, with a focus on this segment of these companies' operations.

      Leading 15 companies and the potential for market growth

      Overall world revenue for Antibacterial Drugs Market will surpass US$xx million in 2020, our work calculates. We predict a growth rate of over xx% from 2020 to 2030.

      Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

      How the Antibacterial Drugs Market report helps you

      In summary, our 391 pages report provides you with the following knowledge:

      • Revenue forecasts to 2030 for Antibacterial Drugs Market, with forecasts for Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others, each forecasted at a global and regional level– discover the industry's prospects, finding the most lucrative places for investments and revenues

      • Revenue forecasts to 2030 for 5 regional and 18 key national markets – See forecasts for the Antibacterial Drugs market in North America, Europe, Asia-Pacific, Latin America and MEA. Also, the report provides forecasts for all the major economies such as U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, GCC, and South Africa

      • Prospects for established firms and those seeking to enter the market– including company profiles for Pfizer Inc., Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, BioVersys AG, Allecra Therapeutics GmbH, Adenium Biotech ApS, Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Inc., AstraZeneca PLC, Allergan, Melinta Therapeutics, SHIONOGI Co., Ltd., and DAIICHI SANKYO COMPANY, LIMITED involved in the Antibacterial Drugs Market.

      Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

      To request a report overview of this report please email contactus@visiongain.com or refer to our website: https://www.visiongain.com/report/antibacterial-drugs-market-2020/

      Did you know that we also offer a report add-on service? Email contactus@visiongain.com to discuss any customized research needs you may have.

      Companies covered in the report include:

      AbbVie Inc.

      Achaogen

      Adenium Biotech ApS

      Alaxia Pharma

      Allecra Therapeutics

      Allergan, Actelion

      AstraZeneca PLC

      Bayer AG

      Biocidium Biopharmaceuticals

      BioVersys AG

      Bugworks

      Cadila Healthcare

      Cellceutix Corporation

      Cempra

      ContraFect

      DAIICHI SANKYO COMPANY, LIMITED

      DebioPharm

      Dr. Reddy's Laboratories

      Eli Lilly and Company

      Evotec Pharmaceuticals

      EYDO Pharma

      Galapagos

      GlaxoSmithKline PLC

      Johnson & Johnson Services, Inc.

      Kyorin Pharmaceutical

      Lupin

      Macleod Pharmaceuticals

      Meiji Seika Pharma

      Melinta Therapeutics

      Merck KGaA

      MerLion Pharmaceuticals

      MGB-Biopharma

      MicuRx Pharmaceuticals

      Nabriva Therapeutics

      Nektar Therapeutics

      Northern Antibiotics

      Novartis AG

      Ostuka

      Paratek Pharmaceuticals

      Pfizer Inc.

      Phico Therapeutics

      Redx Pharma

      Savara Pharmaceuticals

      SHIONOGI Co., Ltd.

      Summit Therapeutics

      The Medicines Company

      Theravance Biopharma

      Torrent Pharmaceuticals

      TTY Biopharma

      Unichem Laboratories

      Wockhardt

      Zydus Pharmaceuticals, Inc.

      Organizations Mentioned in the Report

      Centers for Disease Control and Prevention

      European Medicines Agency (EMA)

      Food and Drug Administration (FDA)

      International Society of Antimicrobial Chemotherapy

      National Institute for Health and Clinical Excellence (NICE)

      National Institutes of Health (NIH)

      World Health Organization (WHO)

      To see a report overview please e-mail contactus@visiongain.com

      RELATED REPORTS:

      Antibiotics Market Report 2019-2029

      Antibiotic Resistance Market Report 2019-2029

      Generic Drugs Market Report 2020-2030

      Allergic Rhinitis Drugs Market Report 2020-2030

      Global Anti-obesity Drugs Market Forecast 2020-2030

      Dermatological Drugs Market Forecast 2020-2030

      Atopic Dermatitis Drugs Market Forecast 2020-2030

      Migraine Drugs Market Analysis Report 2020-2030

      Myelodysplastic Syndrome (MDS) Drugs Report 2020-2030

      Myeloproliferative Disorders Drugs Report 2020-2030

      Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.